NCAM1 and glioblastoma: Moreover, our analysis compared well with RNA-protein detections in an independent study comprised of glioblastoma-isolated immune cells65, which showed higher protein detection for CD36, podoplanin, CD64, CD49f, CD86, CD15, CD56, CD90, CD11a and CD11b, high RNA and protein codetection for CD44 and higher RNA detection for CXCR4 (CD184).